Basal cell carcinoma. Identification and treatment of the high-risk patient

Dermatol Surg. 1996 Mar;22(3):255-61. doi: 10.1111/j.1524-4725.1996.tb00316.x.

Abstract

Background: Some cutaneous basal cell carcinomas have a significant potential to recur, disfigure, and metastasize.

Objectives and methods: The identification and selection of treatment of these high risk carcinomas is based on a review of studies of recurrence, giant size, metastasis, and mortality.

Results: Basal cell carcinomas with any of the following: long duration, location in the mid face or ear, larger than 2 cm, with aggressive histologic subtype, previous treatment, neglected, or a history of radiation exposure, should be considered "high risk."

Conclusion: For basal cell carcinomas with this high risk profile, complete excision by margin control or total destruction should be considered.

Publication types

  • Review

MeSH terms

  • Carcinoma, Basal Cell / epidemiology
  • Carcinoma, Basal Cell / pathology*
  • Carcinoma, Basal Cell / therapy*
  • Combined Modality Therapy
  • Humans
  • Incidence
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy
  • Risk Factors
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / therapy*